본문 바로가기
KERD
논문KCI 등재

Cathelicidin-related Antimicrobial Peptide Contributes to Host Immune Responses Against Pulmonary Infection with Acinetobacter baumannii in Mice

박지연|안재훈|송은정|박종환|김동연|이태성|홍정주|정도현|장아라|강민정
대한면역학회 (The Korean Association of Immunologists)|2020.06|Immune Network|제20권 제3호|pp. 1-13|DOI 10.4110/in.2020.20.e25

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

NeutrophilsInnate immune responseAcinetobacter baumanniiCRAMP

초록

Acinetobacter baumannii is known for its multidrug antibiotic resistance. New approaches to treating drug-resistant bacterial infections are urgently required. Cathelicidin-related antimicrobial peptide (CRAMP) is a murine antimicrobial peptide that exerts diverse immune functions, including both direct bacterial cell killing and immunomodulatory effects. In this study, we sought to identify the role of CRAMP in the host immune response to multidrug-resistant Acinetobacter baumannii. Wild-type (WT) and CRAMP knockout mice were infected intranasally with the bacteria. CRAMP−/− mice exhibited increased bacterial colony-forming units (CFUs) in bronchoalveolar lavage (BAL) fluid after A. baumannii infection compared to WT mice. The loss of CRAMP expression resulted in a significant decrease in the recruitment of immune cells, primarily neutrophils. The levels of IL-6 and CXCL1 were lower, whereas the levels of IL-10 were significantly higher in the BAL fluid of CRAMP−/− mice compared to WT mice 1 day after infection. In an in vitro assay using thioglycollate-induced peritoneal neutrophils, the ability of bacterial phagocytosis and killing was impaired in CRAMP−/− neutrophils compared to the WT cells. CRAMP was also essential for the production of cytokines and chemokines in response to A. baumannii in neutrophils. In addition, the A. baumannii-induced inhibitor of κB-α degradation and phosphorylation of p38 MAPK were impaired in CRAMP−/− neutrophils, whereas ERK and JNK phosphorylation was upregulated. Our results indicate that CRAMP plays an important role in the host defense against pulmonary infection with A. baumannii by promoting the antibacterial activity of neutrophils and regulating the innate immune responses.

Abstract

Acinetobacter baumannii is known for its multidrug antibiotic resistance. New approaches to treating drug-resistant bacterial infections are urgently required. Cathelicidin-related antimicrobial peptide (CRAMP) is a murine antimicrobial peptide that exerts diverse immune functions, including both direct bacterial cell killing and immunomodulatory effects. In this study, we sought to identify the role of CRAMP in the host immune response to multidrug-resistant Acinetobacter baumannii. Wild-type (WT) and CRAMP knockout mice were infected intranasally with the bacteria. CRAMP−/− mice exhibited increased bacterial colony-forming units (CFUs) in bronchoalveolar lavage (BAL) fluid after A. baumannii infection compared to WT mice. The loss of CRAMP expression resulted in a significant decrease in the recruitment of immune cells, primarily neutrophils. The levels of IL-6 and CXCL1 were lower, whereas the levels of IL-10 were significantly higher in the BAL fluid of CRAMP−/− mice compared to WT mice 1 day after infection. In an in vitro assay using thioglycollate-induced peritoneal neutrophils, the ability of bacterial phagocytosis and killing was impaired in CRAMP−/− neutrophils compared to the WT cells. CRAMP was also essential for the production of cytokines and chemokines in response to A. baumannii in neutrophils. In addition, the A. baumannii-induced inhibitor of κB-α degradation and phosphorylation of p38 MAPK were impaired in CRAMP−/− neutrophils, whereas ERK and JNK phosphorylation was upregulated. Our results indicate that CRAMP plays an important role in the host defense against pulmonary infection with A. baumannii by promoting the antibacterial activity of neutrophils and regulating the innate immune responses.

참고문헌 (46)

  1. Doughari HJ, "The ecology, biology and pathogenesis of Acinetobacter spp. : an overview", Microbes Environ, 26, pp.101~112 (2011)
  2. McConnell MJ, "Acinetobacter baumannii : human infections, factors contributing to pathogenesis and animal models", FEMS Microbiol Rev, 37, pp.130~155 (2013)
  3. Alsan M, "Acinetobacter baumannii : an emerging and important pathogen", J Clin Outcomes Manag, 17, pp.363~369 (2010)
  4. Cerqueira GM, "Insights into Acinetobacter baumannii pathogenicity", IUBMB Life, 63, pp.1055~1060 (2011)
  5. Yan Z, "Acinetobacter baumannii infection and IL-17 mediated immunity", Mediators Inflamm, 2016, pp.9834020~ (2016)
  6. Fournier PE, "The epidemiology and control of Acinetobacter baumannii in health care facilities", Clin Infect Dis, 42, pp.692~699 (2006)
  7. Rivas-Santiago B, "Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis", Int J Antimicrob Agents, 41, pp.143~148 (2013)
  8. Sigurdardottir T, "In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37", Antimicrob Agents Chemother, 50, pp.2983~2989 (2006)
  9. Ciornei CD, "Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37", Antimicrob Agents Chemother, 49, pp.2845~2850 (2005)
  10. Wertenbruch S, "The anti-microbial peptide LL-37", cramp is elevated in patients with liver diseases and acts as a protective factor during mouse liver injury, 2015, pp.91, 307~317
  11. Nguyen LT, "The expanding scope of antimicrobial peptide structures and their modes of action", Trends Biotechnol, 29, pp.464~472 (2011)
  12. Agier J, "Cathelicidin impact on inflammatory cells", Cent Eur J Immunol, 40, pp.225~235 (2015)
  13. Feng X, "The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii", Peptides, 49, pp.131~137 (2013)
  14. Spencer JJ, "The effects of antimicrobial peptides WAM-1 and LL-37 on multidrug-resistant Acinetobacter baumannii", Pathog Dis, 76, pp.76~ (2018)
  15. Itou T, "Changes in activation states of murine polymorphonuclear leukocytes(PMN)during inflammation : a comparison of bone marrow and peritoneal exudate PMN", Clin Vaccine Immunol, 13, pp.575~583 (2006)
  16. Celada A, "Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity", J Exp Med, 160, pp.55~74 (1984)
  17. Papayannopoulos V, "Neutrophil extracellular traps in immunity and disease", Nat Rev Immunol, 18, pp.134~147 (2018)
  18. Kang MJ, "IL-10 protects mice from the lung infection of Acinetobacter baumannii and contributes to bacterial clearance by regulating STAT3-mediated MARCO expression in macrophages", Front Immunol, 11, pp.270~ (2020)
  19. McDonald PP, "Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils", Blood, 89, pp.3421~3433 (1997)
  20. Mussbacher M, "Cell type-specific roles of NF-κB linking inflammation and thrombosis", Front Immunol, 10, pp.85~ (2019)
  21. Pillinger MH, "Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts : evidence for regulation of cell-cell adhesion", J Biol Chem, 271, pp.12049~12056 (1996)
  22. Sun P, "Involvement of MAPK", NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation, 2013, pp.8, e69424~
  23. Geisinger E, "Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii", PLoS Pathog, 11, pp.e1004691~ (2015)
  24. Martin TR, "Innate immunity in the lungs", Proc Am Thorac Soc, 2, pp.403~411 (2005)
  25. Bals R, "The peptide antibiotic LL-37", hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface, 1998, pp.95, 9541~9546
  26. Benincasa M, "Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens", J Pept Sci, 15, pp.595~600 (2009)
  27. Byfield FJ, "Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa", J Immunol, 187, pp.6402~6409 (2011)
  28. Dean SN, "Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides : D-enantiomer of LL-37", Front Microbiol, 2, pp.128~ (2011)
  29. Yu PL, "Antimicrobial and immunomodulatory activities of an ovine proline", arginine-rich cathelicidin, 2010, pp.35, 288~291
  30. Kovach MA, "Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia", J Immunol, 189, pp.304~311 (2012)
  31. van Faassen H, "Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice", Infect Immun, 75, pp.5597~5608 (2007)
  32. Qiu H, "Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection", PLoS One, 7, pp.e40019~ (2012)
  33. Kurosaka K, "Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1", mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant, 2005, pp.174, 6257~6265
  34. Mookherjee N, "Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells", Mol Biosyst, 5, pp.483~496 (2009)
  35. Pistolic J, "Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-κB signaling pathway", J Innate Immun, 1, pp.254~267 (2009)
  36. Lee M, "Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation", Biochem Pharmacol, 94, pp.130~141 (2015)
  37. Zheng Y, "Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils", Br J Dermatol, 157, pp.1124~1131 (2007)
  38. Rivas-Santiago B, "Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells", Infect Immun, 76, pp.935~941 (2008)
  39. Kim CH, "Essential role of toll-like receptor 4 in Acinetobacter baumannii-induced immune responses in immune cells", Microb Pathog, 54, pp.20~25 (2013)
  40. Noto MJ, "Toll-like receptor 9 contributes to defense against Acinetobacter baumannii infection", Infect Immun, 83, pp.4134~4141 (2015)
  41. Sabroe I, "The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis", Clin Infect Dis, 41(Suppl 7), pp.S421~S426 (2005)
  42. Di Nardo A, "Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization", J Immunol, 178, pp.1829~1834 (2007)
  43. He Y, "Mechanism and regulation of NLRP3 inflammasome activation", Trends Biochem Sci, 41, pp.1012~1021 (2016)
  44. Kang MJ, "NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice", Immunology, 150, pp.495~505 (2017)
  45. Bakele M, "Localization and functionality of the inflammasome in neutrophils", J Biol Chem, 289, pp.5320~5329 (2014)
  46. Hu Z, "Antimicrobial cathelicidin peptide LL-37 inhibits the LPS", ATP-induced pyroptosis of macrophages by dual mechanism, 2014, pp.9, e85765~

이 간행물의 다른 논문 (7건)

The Roles of CCR7 for the Homing of Memory CD8+ T Cells into Their Survival Niches정용우, 송헌주, 최한별pp. 1-15Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors이정은, 신의철, 김영철, 김진현, 박동일, 정재욱, 박철규, 권인선, 오인재, 권계철, 강다현, 선푸름pp. 1-11TLR10 and Its Unique Anti-Inflammatory Properties and Potential Use as a Target in TherapeuticsFaith Fore, Cut Indriputri, Janet Mamutse, Jusak Nugrahapp. 1-10The Emerging Role of Eosinophils as Multifunctional Leukocytes in Health and Disease정윤재, 김형진pp. 1-14Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis최재훈, 이지혜pp. 1-21
원문 보기